EQUILLIUM, INC. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
EQUILLIUM, INC. (EQ) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $271.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-25
- EQUILLIUM, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $271.00K, a 2.26% increase from fiscal 2024.
- EQUILLIUM, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $265.00K, a 134.51% increase from fiscal 2023.
- EQUILLIUM, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $113.00K, a 71.17% decline from fiscal 2022.
- EQUILLIUM, INC. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $392.00K, a 29.24% decline from fiscal 2021.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 10 month | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | $271.00K 10-K · filed 2026-03-25 | ||
| 2024-12-31 | $265.00K 10-K · filed 2026-03-25 | ||
| 2023-12-31 | $113.00K 10-K · filed 2025-03-27 | ||
| 2022-12-31 | $392.00K 10-K · filed 2024-03-25 | ||
| 2021-12-31 | $554.00K 10-K · filed 2023-03-23 | ||
| 2020-12-31 | $319.00K 10-K · filed 2022-03-23 | ||
| 2019-12-31 | $271.00K 10-K · filed 2021-03-24 | ||
| 2018-12-31 | $81.00K 10-K · filed 2020-03-26 | $81.79K 10-K · filed 2019-03-27 | |
| 2017-12-31 | $18.85K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |